Skip to main content
. 2020 Apr 17;14(3):933–942. doi: 10.1093/ckj/sfaa041

Table 2.

Time intervals, eGFR levels and eGFR progression rates at different time points prior to first dialysis in patients with optimal DI and SDI

Variable Patients included (n) All patients Optimal DI SDI
Time interval, months
 Referral dialysis 1320 29.0 (5.6–59.7) 40.4 (18.5–67.4) 7.5 (0.2–45.8)
 Information dialysis 1204 4.0 (0.5–10.1) 6.7 (3.0–14.0) 0.3 (0.0–3.8)
 Access prescription dialysis 1124 1.1 (0–2.9) 2.3 (1.2–5.0) 0.0 (0.0–0.3)
 Access placement dialysis 939 0.5 (0–1.6) 1.2 (0.7–3.4) 0.0 (0.0–0.0)
eGFR, mL/min/1.73 m2
 Referral 1414 20.7 (11.5–32.4) 23.0 (15.0–34.0) 15.9 (7.0–30.4)
 6 months prior 1202 12.0 (9.6–16.5) 11.1 (9.2–13.6) 16.7 (11.7–26.2)
 3 months prior 1225 10.0 (8.0–13.5) 9.3 (7.6–11.4) 13.5 (9.5–20.6)
 Dialysis information 1448 10.1 (7.4–12.8) 10.9 (8.8–13.4) 8.1 (5.4–11.5)
 Access prescription 1537 7.9 (6.0–10.0) 8.6 (7.1–10.5) 6.6 (4.7–8.7)
 Access placement 1499 7.5 (5.5–9.7) 8.3 (6.7–10.4) 6.2 (4.4–8.1)
 First dialysis 1571 6.6 (4.9–8.4) 7.0 (5.5–8.9) 6.0 (4.3–7.9)
ΔeGFR, mL/min/1.73 m2/year
 Referral dialysis 1320 5.3 (2.8–10.7) 4.8 (2.8–7.9) 7.6 (3.1–21.2)
 6 months prior dialysis 1194 8.5 (4.1–16.5) 6.5 (3.2–10.9) 16.7 (9.1–35.0)
 6–3 months prior 1147 6.9 (1.8–14.6) 6.1 (1.6–11.8) 8.9 (2.7–22.3)
 3 months prior dialysis 1219 9.6 (3.8–21.0) 7.0 (2.3–13.4) 21.9 (10.8–54.3)
 Information dialysis 1204 5.6 (2.0–12.1) 4.8 (1.9–9.2) 9.5 (2.8–25.7)
 Access prescription dialysis 1124 4.3 (−0.1 to 12.3) 3.8 (−0.3 to 9.2) 10.4 (0.0–37.5)
 Access placement dialysis 939 3.9 (−0.6 to 12.3) 3.9 (−0.5 to 11.1) 0.9 (−3.6 to 44.9)

Median values (IQR). All P < 0.001. Δ, rate of change of eGFR. Positive values mean falling eGFR.